glucagon glp 1 Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease GLP-1 for Weight Loss and
Description
Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

This integrated system supports your fasting routine, cellular performance, and metabolic balancehelping you burn fat, sustain energy, and feel in control

Not for under-18s, pregnant or breastfeeding women, or those sensitive to caffeine
pharmacy benefits with BCBSIL, including how you may be eligible for the Affinity Medication Delivery Program.

Additionally, encouraging results from SURMOUNT trials and ongoing SURPASS-CVOT studies will shed more light on cardiovascular safety in the future
